Construction of the pulmonary bio-adhesive delivery system of nintedanib nanocrystalline for effective treatment of pulmonary fibrosis
- 5 June 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 660, 124302
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072052)
This publication has 43 references indexed in Scilit:
- Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosisAsian Journal of Pharmaceutical Sciences, 2022
- Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studiesDrug Delivery and Translational Research, 2022
- Emerging trends in inhaled drug deliveryAdvanced Drug Delivery Reviews, 2020
- Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeabilityCarbohydrate Polymers, 2019
- Engineered cell and tissue models of pulmonary fibrosisAdvanced Drug Delivery Reviews, 2018
- Drug nanocrystals – Versatile option for formulation of poorly soluble materialsInternational Journal of Pharmaceutics, 2018
- Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluationCarbohydrate Polymers, 2018
- Inhaled hyaluronic acid microparticles extended pulmonary retention and suppressed systemic exposure of a short-acting bronchodilatorCarbohydrate Polymers, 2017
- Amorphous powders for inhalation drug deliveryAdvanced Drug Delivery Reviews, 2016
- Delivery strategies for sustained drug release in the lungsAdvanced Drug Delivery Reviews, 2014